Method of and compositions for treating destructive periodontal disease
US4933172A · kind A · utility
9Cited by
12References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 1988 |
| Grant date | Jun 12, 1990 |
| Priority date | — |
| Expiry date | Oct 6, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
2-(2,6-Dichloro-3-methylphenylamino)benzoic acid and its physiologically acceptable salts are effective in inhibiting the conversion of gingivitis to periodontitis and thus useful in treating destructive periodontal disease. The therapeutic agent can be applied directly to the gingival tissue in a topically administerable pharmaceutical composition or can be introduced and released in the buccal cavity for contact with the gingival tissue through the fluid motion present in the mouth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.